A novel matrix-degrading protease in hormone-dependent breast cancer.
Dickson
R B
RB
Lombardi Cancer Research Center, Georgetown University, Washington DC 20007.
Shi
Y E
YE
Johnson
M D
MD
D001940:Breast / Q000201:enzymology*; D001943:Breast Neoplasms / Q000145:classification / Q000201:enzymology* / Q000473:pathology*; D005260:Female; D018093:Gelatinases / Q000032:analysis / Q000378:metabolism*; D006023:Glycoproteins / Q000032:analysis / Q000378:metabolism; D006801:Humans; D020778:Matrix Metalloproteinase 2; D061965:Matrix Metalloproteinase Inhibitors; D008666:Metalloendopeptidases / Q000032:analysis / Q000378:metabolism*; D009362:Neoplasm Metastasis; D009364:Neoplasm Recurrence, Local; D011506:Proteins / Q000032:analysis / Q000378:metabolism; D019716:Tissue Inhibitor of Metalloproteinase-2; D019714:Tissue Inhibitor of Metalloproteinases
D006023:Glycoproteins; D061965:Matrix Metalloproteinase Inhibitors; D011506:Proteins; D019714:Tissue Inhibitor of Metalloproteinases; D019716:Tissue Inhibitor of Metalloproteinase-2; D018093:Gelatinases; D008666:Metalloendopeptidases; D020778:Matrix Metalloproteinase 2